Innovation and imitation,opportunity and challen±λ♦ge
Asia-Pacific Pharma IP Ω Leader summit2019---14th-15th NOV, Beijin¶g CHINAOn March 19, 2019, the W ™↔ orld Intellectual Property Organizat>↔ion (WIPO) published its global intellectual ₹♦ property report 2018.Asian innovators β♦filed more than half of their international pa∑<¶λtent applications through WIPO for the first tγ•ime in 2018, with significant growth in China, ↔₹×αIndia and South Korea, the report noted. A"≤s a technology-intensive industry, pharmaceutic∏δ♥al industry attaches great imporδ® ∑tance to patent application and ¶₽←intellectual property pro♥✔tection.In recent years, the s∑✔ize of the global pharmaceutical market ha✘φ♠s maintained a steady growth, with China, South ' Korea, India and other emeσ>rging markets presenting a rapid growth m™ omentum. Due to the different ≠£≤intellectual property policies of different count≥∑® ries, the strategic layou'β&>t of global intellectual property, tπφ$&he differences of pharmace©•utical intellectual property pol™ Ωicies of Asia-pacific coun>tries, the patent review pr₹✔©ocess, litigation procedures and Generic d×<>rug patent strategy have gradua÷πlly become the hot s'€pots of the pharmaceutical int∏ellectual property in뱕dustry.In this context, the 2019 €♣↔<Asia-pacific Pharmaceutical IP Le׶'βader Summit will be he∞•βld in Beijing on Nov∞®"εember 14-15, and will attract more than 500 inφ↕♥≥dustry experts from domestic and foreign pharmac↓∏eutical companies, biotechnology companies, goα©αvernments, associations,"∑ law firms, intellec←tual property agents and o®πther companies to attend.Agenda Framework≈→¥λ:Section 1:Interpretation of Policy:♦• Development of Pharmaceutical IP under th☆ ♦'e New Legislative Landscape Section♣≠ 2:Pharmaceutical R&D✘♠ Innovation and IP Protection -- G>εlobal VisionSection 3:Case Shar↓✔βing of Pharmaceutical Pate¶♣nt Invalidity, Infringement, Litigat§<β♠ionSection 4:Opportunities ↓πand challenges for gλ®'enerics companies under the new situatα✔∞ion HOTSPOT:ü γλλ←; Medical Policy Interpretation unde✘ r the Background of Patent Law Amendmentü T★∞∞™he innovation of Judicial Mech♠anism Promotes the Development of Pharma✘ ceutical Intellectual Propertyü Inte←≤∏ llectual Property Mana±←σgement Experience in Multinational Pharmac£ eutical Companies, Pate§₩÷nt Layout Strategy, Litigation Strategyü&nbs→ ∞p; he Data Protection Regulations of Drug Test—N≠₽ew Eraü Trade Secrets and Patent Layout in☆☆≈> the Medical Fieldü&n>≤bsp; Establishing The Internal Intellec÷ tual Property System under Thσ"♥★e New Legislative Landsca≥π±peü Opportunities and Chal™£♣lenges of Pharmaceutical Enterprises u←©≈γnder Patent Term Compensation System--- Global∑$ ® Vision and Its Implications fδ£¥or Chinaü Latest ≤γChanges in European Patent Application and Rev∑ iew Proceduresü Analysis o™≠f Hot Cases of Recent ★↑'Patent Invalidationü The Procedure of Am≈£γ∏erican Pharmaceutical Patent litigation and ≠↓its Enlightenment to Chinese Pharmaceutic•☆al Enterprises &'nbsp;ü Application techniques and prot γ↑<ection strategies for European and American b₩δiomedical patentsü Chan↔÷ges in standards for creativ'Ω♥₹e review of patentsü European, Ameriβ₩↓✔can and Japanese Medical ₽©Patent Examination Cases and its£© implications for DomesticPharmaceutical Co¶>÷≤mpaniesü Recent Hot Patent Infrin'↕gement Cases Analysi₽←★ sü The Strategy of Indian Generic Drug Comp®★anies in R&D and P≈€re-PAü How to avoid the Patent Trap in Gene↕✔ric Drug Developmentü The Strategy of Gener★≠$ ic Drug Companies to Enter the European ∑<₩and American Marketsü Paten∞→>₩tability in Europe, the United States an∑$ d Chinaü Patent l★×itigation in Europeü€σ" Doubts around the Unifε•₩εied Patent Court (UPC) agreement an ☆÷→d Brexitü Second medical use patentsCompos↓•≤∑ition of participants:  $α®∑;Summit highlights:10+ Hot topic20+ α∏ΩAuthoritative speech5 0+ ©γIndustry media4 0+ BIC110+pharma company →♣500+專業(yè)參會(huì)嘉賓 ✔ &n↑φbsp; &nb₩ sp; "✔✘ Professional participantsOfficial registrβ ₽ation and consultation channels:Contact:AnnPh♠πone: 021-65650305Emai£✔♥αl:Marketing@zenseegr§¥oup.comhttp://en.zenseegr$×oup.com/p/510934/